Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type of drug they contain, and how the medications are delivered to the lungs.

“There are many people on this drug, and they will benefit by another generic version of it,” Dr. Harlan Krumholz, a cardiologist at Yale University and Yale New Haven Hospital, told CNN by emai ...

Nebulizer If you don't clean it, there's a risk of infection from build-up of debris ... American Academy of Allergy, Asthma, and Immunology. Dry powder inhaler definition. Asthma and Allergy ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...

The branded drug costs between $500 and $815 per package, depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for ...

The U.S. Federal Trade Commission, which has warned pharmaceutical companies against submitting irrelevant patents to the FDA to limit generic competition, supported Amneal's lawsuit. A Teva ...